Therefore, this assay was subsequently used to identify genetic alterations in six major driver genes of NSCLC including KRAS, EGFR, NRAS, BRAF, ALK and ROS1 for the cohort of 350 NSCLC patients. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.